Phase 3 clinical trial investigating the effect of selenium supplementation in men at high‐risk for prostate cancer

Amit M. Algotar,M. Suzanne Stratton,Frederick R. Ahmann,James Ranger-Moore,Raymond B. Nagle,Patricia A. Thompson,Elizabeth H. Slate,Chiu-Hsieh Hsu,Bruce L. Dalkin,Puneet Sindhwani,Michael Holmes,John A. Tuckey,David L. Graham,Howard L. Parnes,Lawrence C. Clark,Steven P. Stratton

Phase 3 clinical trial investigating the effect of selenium supplementation in men at high‐risk for prostate cancer

2013

Amit M. Algotar
M. Suzanne Stratton
Frederick R. Ahmann
James Ranger-Moore
Raymond B. Nagle
Patricia A. Thompson
Elizabeth H. Slate
Chiu-Hsieh Hsu
Bruce L. Dalkin
Puneet Sindhwani
Michael Holmes
John A. Tuckey
David L. Graham
Howard L. Parnes
Lawrence C. Clark
Steven P. Stratton

Purpose This study was conducted to investigate the effect of Se supplementation on prostate cancer incidence in men at high risk for prostate cancer.

Keywords:

Cancer research
Prostate-specific antigen
Prostate cancer
Phases of clinical research
Medicine
Oncology
Internal medicine
prostate cancer incidence
follow up studies
Endocrinology
Selenium
Gynecology
Proportional hazards model

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations